Find your path to Sujata
30 people in our graph share verified history with Sujata — schools, employers, funds. One of them is your warm intro.
Marianne UtengunlockedSujata: together at CatalYm (2025–2026)
×2Sujata: together at Onyx Pharmaceuticals, Inc., an Amgen subsidiary
×6Sujata: together at CatalYm
×3Sujata: together at Insilico Medicine
Chief Medical Officer at CatalYm
Intro paths
→
In turn, Sujata can intro founders to CatalYm's investors below.
CatalYm's investors · 8
Bayern KapitalLandshut · $275K – $55M checksBioGeneration VenturesNaarden · since 2020Bioqube VenturesBrussels · $108K – $6.5M checksCanaan PartnersStamford · $500K – $20M checks · since 2024coparionCologne · $540K – $8.6M checks · since 2020ForbionNaarden · since 2020Jeito CapitalParisNovartis Venture FundBasel · $5M – $25M checks · since 2020
Co-founders at CatalYm
JW
Jörg WischhusenScientific Co-founder
Experience
- CatalYm GmbHChief Medical Officercurrent2025 — present
- Insilico MedcineChief Medical Officer2023 — 2025
- Insilico MedicineSenior Vice President, Global Clinical Development2022 — 2023
- Eli Lilly and CompanyAssociate VP, Global Clinical Development2022
- ARMO BioSciences, A Wholly Owned Subsidiary of Eli LillyExecutive Director, Clinical Development Lead2018 — 2022Redwood City, CA
- Eli Lilly and CompanyLead, IIR and Collaborative Research2017 — 2018Indianapolis, Indiana Area
- Bristol-Myers SquibbSenior Medical Director2014 — 2017Princeton, NJ
- Onyx Pharmaceuticals, Inc., an Amgen subsidiarySenior Medical Director2008 — 2014
Skills & more
Medicine
From Sujata's professional profile.
Frequently asked questions
- Who is Sujata Rao?
- Chief Medical Officer at CatalYm
- Where does Sujata Rao work?
- Sujata Rao is Chief Medical Officer at CatalYm.
- Where did Sujata Rao go to school?
- Sujata Rao studied at Memorial Sloan Kettering Cancer Institute , New York (Medical Oncology/Hematology Fellowship).
Shared employers
Also worked at CatalYm GmbH11
Marianne UtengManaging Director at Novartis Venture FundDaniela CoutoGeneral Partner at BioGeneration VenturesMarc LohrmannManaging Partner at Vesalius Biocapital III Partners SàRLPascal TouchonOperating Partner at Jeito CapitalHelmsManaging Director & Chief Financial Officer at Longitude CapitalJon EdwardsGeneral Partner at Forbion
+ 5 more
Also worked at Insilico Medicine7
Krish RamaduraiPartner at AIX VenturesGarri ZmudzeManaging Partner at LongeVCProf. Dr. Evelyne Yehudit BischofScientific Advisor at MaximonKristen FortneyExecutive Officer, Director at BioAge LabsNirav JhaveriExecutive Officer at Opus GeneticsAlex ZhavoronkovFounder & CEO at Insilico Medicine
+ 1 more
Also worked at Eli Lilly and Company189
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 183 more
Also worked at Bristol-Myers Squibb158
Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners
+ 152 more